Piramal Enterprises Limited (PEL) is one of India’s large diversified companies, with a presence in Financial Services, Pharmaceuticals and Healthcare Insight & Analytics. PEL’s consolidated revenues were over $1.6 billion in FY2018, with around 46% of revenues generated from outside India.
In Financial Services, Piramal Capital & Housing Finance Limited (PCHFL), wholly owned subsidiary of Piramal Enterprises Limited (the flagship company of Piramal Group), is registered as a housing finance company with National Housing Bank (NHB) and engages in various financial services businesses. It provides both wholesale and retail funding opportunities across sectors. In real estate, the platform provides housing finance and other financing solutions across the entire capital stack ranging from early stage private equity, structured debt, senior secured debt, construction finance and flexi lease rental discounting. The wholesale business in non-real estate sector includes separate verticals- Corporate Finance (CFG) and Emerging Corporate Lending (ECL). CFG provides customised funding solutions to companies across sectors such as infrastructure, renewable energy, roads, industrials, auto components etc., while ECL focuses on lending towards Small and Medium Enterprises (SMEs).
PCHFL through its group companies provides customised strategies for institutional and retail investors (through Piramal Fund Management) and has strategic partnerships with leading global pension funds such as CPPIB, APG and Ivanhoe Cambridge. PEL entered into a JV with Bain Capital Credit (the credit arm of Bain Capital) to tap into distressed asset resolution opportunity in India.
In Pharma, through an end-to-end manufacturing capabilities across 13 global facilities and a large global distribution network to over 100 countries, PEL sells a portfolio of niche differentiated pharma products and provides an entire pool of pharma services (including in the areas of injectable, HPAPI etc.). The Company is also strengthening its presence in the Consumer Product segment in India.
PEL’s Healthcare Insight & Analytics business, Decision Resources Group, is the premier provider of healthcare analytics, data & insight products and services to the world’s leading pharma, biotech and medical technology companies and enables them to take informed business decisions.
Market Capitalisation as
on March 31, 2018
DOLLAR RAISE I N F Y2018
We strive for a deeper understanding of our domain.
We aspire to do things creatively.
We are empowered to act decisively and create value.
We are consistent in our thought, speech and action.
We protect and enhance the interests of our customers, community, employees, partners and shareholders.
We aspire to be the best, yet strive to be humble.
We strive to achieve market leadership in scale and profitability, wherever we compete.
We aspire to build businesses that anticipate, adapt and endure for generations.
Our Purpose — Doing Well and Doing Good
(Real Estate, Corporate Finance Group, Emerging Corporate Lending)
(20% in SCL; 10% in STFC & 10% in SCUF)
(Partnerships with APG, Bain Capital Credit, CPPIB, CDPQ)
(for Distressed Assets)
(Global Pharma Products & Global